An examination of four cases of botulism following cosmetic injections to the face indicates that the adults received a highly concentrated, unlicensed preparation that resulted in toxin levels up to ...

Spasticity is a disabling complication of stroke, and it is uncertain whether intramuscular injections of botulinum toxin type A reduce disability in persons with spasticity of the wrist and fingers ...

BATON ROUGE, La. — The Louisiana Department of Health is urging residents to steer clear of botulinum toxin (commonly called Botox) injections from unlicensed sources or in non-medical settings. On ...

A 2012 Cochrane systematic review (assessed as up to date September 2011, Nelson et al. 2012) investigated non-surgical therapy for anal fissure. A second systematic review of clinical trials ...

The CDC reported that three individuals were hospitalized with botulism-type symptoms in May and June following self-injection of botulinum toxin they purchased online for cosmetic use. The case ...

Berlin, Germany - A single injection of botulinum A toxin appears to decrease chronic plantar fasciitis pain, with the improvement lasting at least a year [1]. The findings come from a pilot study in ...

Botulinum toxin is the most common non-surgical procedure performed globally, with nearly nine million procedures estimated to take place each year. In the UK alone, around 900,000 botulinum toxin ...

The purpose of this study is to evaluate the efficacy and safety of botulinum toxin injection as a primary treatment for strabismus in a cohort of patients with nasopharyngeal carcinoma (NPC)-related ...

Please provide your email address to receive an email when new articles are posted on . Botulinum toxin has often been used to treat head tremor despite limited evidence of its use. The current study ...

PHOENIX -- Botulinum toxin injections offered relief from sialorrhea, or excessive saliva production, in patients with amyotrophic lateral sclerosis (ALS), according to a small study. The ...

No cost-effectiveness studies were identified for the use of botulinum toxin type A to treat chronic anal fissure in a UK setting were identified. One US-based cost-effectiveness study (Essani et al.